Clinical Trials Directory

Trials / Unknown

UnknownNCT06288074

Diagnosis and Treatment Strategy Optimization of Severe Pneumonia Based on Multi-omics Data Integration

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Severe community-acquired pneumonia still has a high incidence and mortality, but the molecular mechanism and prognostic biomarkers of severe community-acquired pneumonia caused by different pathogens are still unclear, and the best treatment strategy has not been determined. Based on this, this project intends to take patients with severe community-acquired pneumonia caused by different pathogens as the research object, explore the molecular mechanism of severe community-acquired pneumonia from multiple angles, integrate relevant research data to evaluate the rationality of initial empirical medication, and lay the foundation for precise treatment of severe pneumonia. The research results will help to develop a new rapid and accurate target for clinical diagnosis and efficacy evaluation of severe pneumonia, and build a precise treatment system for severe pneumonia.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMulti-omics testsBiological sample collection for Multi-omics tests

Timeline

Start date
2024-03-10
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2024-03-01
Last updated
2024-03-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06288074. Inclusion in this directory is not an endorsement.